Persistent Long-Term Risk Of Liver Related Complications In Hepatitis C Virus Patients After Antiviral Therapy-Data From The German Hepatitis C-Registry (Dhc-R)

Heiner Wedemeyer,Peter Buggisch,Stefan Mauss,Albrecht Stoehr,Hartwig Klinker,Klaus Boeker,Gerlinde Teuber,Yvonne Serfert,Markus Cornberg,Heinz Hartmann,Dietrich Hueppe,Christoph Sarrazin,Karl-Georg Simon, Stefan Zeuzem,Thomas Berg

JOURNAL OF HEPATOLOGY（2021）

引用 1|浏览12

暂无评分

摘要

Background and aims Direct acting antivirals against hepatitis C improve the short-term outcome of patients with chronic hepatitis C. The long-term clinical course after interferon-free treatment of chronic hepatitis C has rarely been studied in large real-world cohorts. We here present data on 10,448 patients being followed for up to 7 years after DAA therapy in the German Hepatitis C-Registry.

查看译文

关键词

hcv patients,antiviral therapy,liver,long-term,c-registry

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要